1. Home
  2. CHEK vs ADXN Comparison

CHEK vs ADXN Comparison

Compare CHEK & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • ADXN
  • Stock Information
  • Founded
  • CHEK 2004
  • ADXN 2002
  • Country
  • CHEK Israel
  • ADXN Switzerland
  • Employees
  • CHEK N/A
  • ADXN N/A
  • Industry
  • CHEK Medical Electronics
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHEK Health Care
  • ADXN Health Care
  • Exchange
  • CHEK Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • CHEK 9.0M
  • ADXN 8.0M
  • IPO Year
  • CHEK 2015
  • ADXN N/A
  • Fundamental
  • Price
  • CHEK $0.93
  • ADXN $7.59
  • Analyst Decision
  • CHEK
  • ADXN Strong Buy
  • Analyst Count
  • CHEK 0
  • ADXN 1
  • Target Price
  • CHEK N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • CHEK 88.2K
  • ADXN 24.6K
  • Earning Date
  • CHEK 02-18-2025
  • ADXN 03-24-2025
  • Dividend Yield
  • CHEK N/A
  • ADXN N/A
  • EPS Growth
  • CHEK N/A
  • ADXN N/A
  • EPS
  • CHEK N/A
  • ADXN 0.06
  • Revenue
  • CHEK N/A
  • ADXN $701,260.00
  • Revenue This Year
  • CHEK N/A
  • ADXN N/A
  • Revenue Next Year
  • CHEK N/A
  • ADXN N/A
  • P/E Ratio
  • CHEK N/A
  • ADXN $1.04
  • Revenue Growth
  • CHEK N/A
  • ADXN N/A
  • 52 Week Low
  • CHEK $0.56
  • ADXN $6.81
  • 52 Week High
  • CHEK $3.45
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 42.16
  • ADXN 48.97
  • Support Level
  • CHEK $0.81
  • ADXN $7.20
  • Resistance Level
  • CHEK $1.00
  • ADXN $8.04
  • Average True Range (ATR)
  • CHEK 0.10
  • ADXN 0.51
  • MACD
  • CHEK -0.05
  • ADXN 0.00
  • Stochastic Oscillator
  • CHEK 13.98
  • ADXN 47.95

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: